Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
about
From animal models to human disease: a genetic approach for personalized medicine in ALSAutophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALSNeurodegenerative diseases: expanding the prion conceptC9orf72's Interaction with Rab GTPases-Modulation of Membrane Traffic and AutophagyG-quadruplexes: Emerging roles in neurodegenerative diseases and the non-coding transcriptomeChronic effects of mild neurotrauma: putting the cart before the horse?Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective.The calcium-binding protein EFhd2 modulates synapse formation in vitro and is linked to human dementia.Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.Special Issue on amyotrophic lateral sclerosis.Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.Microstructural Correlates of Emotional Attribution Impairment in Non-Demented Patients with Amyotrophic Lateral SclerosisTMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic miceTelephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS).Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update.Current developments in gene therapy for amyotrophic lateral sclerosis.Cognitive Profile of C9orf72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementiaTranscultural validation of the ALS-CBS Cognitive Section for the Brazilian population.Pathogenesis of amyotrophic lateral sclerosis.Molecular Genetics of Neurodegenerative Dementias.Could Sirtuin Activities Modify ALS Onset and Progression?Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.Chronic traumatic encephalopathy: A paradigm in search of evidence?Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD.Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: evidence from MRI and MEG studies.Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.Antibody Therapeutics Targeting Aβ and Tau.Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.Involvement of the caudate nucleus head and its networks in sporadic amyotrophic lateral sclerosis-frontotemporal dementia continuum.Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition.Familial Amyotrophic Lateral Sclerosis.Patient-Derived iPSCs and iNs-Shedding New Light on the Cellular Etiology of Neurodegenerative Diseases.Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS.
P2860
Q26741250-6FA511D4-B179-4C3F-BF4E-301A907008F1Q26796599-09B5F2F0-19F7-4864-BC68-A1CE74D146A6Q27011744-BC3BAA12-061F-4142-9475-E9E031D5F600Q28069365-AF4F8852-8D71-424B-9365-0EC219B764BDQ28084249-AC465532-D80C-45EB-8B49-AEDB608B5E7BQ28394156-59ACEEB6-8201-41E9-88A5-5B54EA8D609AQ33588537-7691E52B-3F27-4260-87D6-8CEEF195442FQ34549505-F6705075-98A3-43E3-8AE6-432F406D5C15Q35752114-7CE68261-DC04-49CD-BEFA-45C93729E9E5Q36025143-6354D80D-DBEB-4DA1-968D-E195E0211058Q36073666-28FC9B3C-9A34-461A-ADC2-AE6897246B8EQ36101378-DA3BC643-DF79-4C7D-8473-71CB3AE063C5Q36364206-346EA10E-3935-4E5E-9F4E-2C1C61EFC5FFQ37223636-E9086995-35D9-4517-9CC0-D95913D34D2FQ37708635-C5FDA6BF-A0E2-497D-8E96-2CA6879FD9A1Q38392505-84423885-113B-4E94-8FA3-A6FA594A4B57Q38470242-DBC34BA6-1484-4CFD-A4F7-E2518399F539Q38551786-2CDA2344-D951-4DF9-8D18-7C944AA37EE3Q38625515-0DD03FD1-F74B-4515-B8EB-59F294BBCAEBQ38636765-44BA44E0-0881-40AC-9935-E9DB53157F1DQ38830460-2BD326AD-1590-4C79-A9A8-2A3CDFCF7D87Q38906347-F9153835-6E1E-412A-A4E7-41946C90293DQ39035458-B9703D60-5D49-4958-88B6-165B846510B0Q39036105-2E9DEB78-4E11-4A82-A940-E66A2D1FE635Q46441393-3C1234C1-23D0-4B74-82A9-12291A1100E9Q46744517-38E85670-B1E7-4729-BE0B-D8A46B848D9FQ47403937-B0D35311-7EAF-4E3A-9D24-BCCA06CCA2E4Q47404494-654091F4-6919-4E9A-96FF-A8B6BB3E7004Q47424783-A2DF24B0-EA18-4433-9C3D-30F345EB80B3Q47591552-9F9062DB-7E99-4B4A-A110-A613D5E2FF7CQ48269119-446D8CFE-C2C6-4A5C-9F67-352D78D95C98Q48492743-B9F91FD7-D96A-428A-ABAD-21AB45110F3BQ50706880-0F900BCC-814E-4C16-BA6A-057A86CA1588Q54158931-74EF8DB6-E359-4BF5-A12E-AD83BB78DD6BQ55220858-AFF871E3-5720-41CF-941B-D3A6DE7B733EQ55261436-74C9F3A9-EE3F-453F-BE24-F8C1339EA760Q55399094-E00AF508-CA71-483D-A97A-F459D35F86B4
P2860
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
@en
type
label
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
@en
prefLabel
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
@en
P2860
P921
P1476
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS.
@en
P2093
Janis Bennion Callister
P2860
P356
10.1016/J.EXPNEUROL.2014.06.001
P407
P478
P577
2014-06-08T00:00:00Z
2014-12-01T00:00:00Z